222 related articles for article (PubMed ID: 30999003)
1. Fatty acid binding protein 4 (FABP4) as a potential biomarker reflecting myocardial lipid storage in type 2 diabetes.
Rodríguez-Calvo R; Girona J; Rodríguez M; Samino S; Barroso E; de Gonzalo-Calvo D; Guaita-Esteruelas S; Heras M; van der Meer RW; Lamb HJ; Yanes O; Correig X; Llorente-Cortés V; Vázquez-Carrera M; Masana L
Metabolism; 2019 Jul; 96():12-21. PubMed ID: 30999003
[TBL] [Abstract][Full Text] [Related]
2. FABP4 inhibitor BMS309403 decreases saturated-fatty-acid-induced endoplasmic reticulum stress-associated inflammation in skeletal muscle by reducing p38 MAPK activation.
Bosquet A; Girona J; Guaita-Esteruelas S; Heras M; Saavedra-García P; Martínez-Micaelo N; Masana L; Rodríguez-Calvo R
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jun; 1863(6):604-613. PubMed ID: 29550588
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid binding protein 4 regulates intracellular lipid accumulation in human trophoblasts.
Scifres CM; Chen B; Nelson DM; Sadovsky Y
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1083-91. PubMed ID: 21525163
[TBL] [Abstract][Full Text] [Related]
4. Regulative effect of maternal serum fatty acid-binding protein 4 on insulin resistance and the development of gestational diabetes mellitus.
Duan B; Li Y; Dong K; Sun Y; Ma A; Yang X
Prostaglandins Leukot Essent Fatty Acids; 2020 Dec; 163():102213. PubMed ID: 33260074
[TBL] [Abstract][Full Text] [Related]
5. High Fat Diet Upregulates Fatty Acid Oxidation and Ketogenesis via Intervention of PPAR-γ.
Sikder K; Shukla SK; Patel N; Singh H; Rafiq K
Cell Physiol Biochem; 2018; 48(3):1317-1331. PubMed ID: 30048968
[TBL] [Abstract][Full Text] [Related]
6. Identification of a potential biomarker for FABP4 inhibition: the power of lipidomics in preclinical drug testing.
Suhre K; Römisch-Margl W; de Angelis MH; Adamski J; Luippold G; Augustin R
J Biomol Screen; 2011 Jun; 16(5):467-75. PubMed ID: 21543640
[TBL] [Abstract][Full Text] [Related]
7. Cardiac metabolism in a new rat model of type 2 diabetes using high-fat diet with low dose streptozotocin.
Mansor LS; Gonzalez ER; Cole MA; Tyler DJ; Beeson JH; Clarke K; Carr CA; Heather LC
Cardiovasc Diabetol; 2013 Sep; 12():136. PubMed ID: 24063408
[TBL] [Abstract][Full Text] [Related]
8. Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes.
de Gonzalo-Calvo D; van der Meer RW; Rijzewijk LJ; Smit JW; Revuelta-Lopez E; Nasarre L; Escola-Gil JC; Lamb HJ; Llorente-Cortes V
Sci Rep; 2017 Mar; 7(1):47. PubMed ID: 28246388
[TBL] [Abstract][Full Text] [Related]
9. Knocking out or pharmaceutical inhibition of fatty acid binding protein 4 (FABP4) alleviates osteoarthritis induced by high-fat diet in mice.
Zhang C; Chiu KY; Chan BPM; Li T; Wen C; Xu A; Yan CH
Osteoarthritis Cartilage; 2018 Jun; 26(6):824-833. PubMed ID: 29549054
[TBL] [Abstract][Full Text] [Related]
10. Associations between Fatty Acid-Binding Protein 4⁻A Proinflammatory Adipokine and Insulin Resistance, Gestational and Type 2 Diabetes Mellitus.
Trojnar M; Patro-Małysza J; Kimber-Trojnar Ż; Leszczyńska-Gorzelak B; Mosiewicz J
Cells; 2019 Mar; 8(3):. PubMed ID: 30857223
[TBL] [Abstract][Full Text] [Related]
11. Cardiac metabolic modulation upon low-carbohydrate low-protein ketogenic diet in diabetic rats studied in vivo using hyperpolarized
Abdurrachim D; Teo XQ; Woo CC; Ong SY; Salleh NF; Lalic J; Tan RS; Lee PTH
Diabetes Obes Metab; 2019 Apr; 21(4):949-960. PubMed ID: 30536560
[TBL] [Abstract][Full Text] [Related]
12. Combined treatment with FABP4 inhibitor ameliorates rosiglitazone-induced liver steatosis in obese diabetic db/db mice.
Chen MT; Huang JS; Gao DD; Li YX; Wang HY
Basic Clin Pharmacol Toxicol; 2021 Sep; 129(3):173-182. PubMed ID: 34128319
[TBL] [Abstract][Full Text] [Related]
13. ATF3 expression in cardiomyocytes preserves homeostasis in the heart and controls peripheral glucose tolerance.
Kalfon R; Koren L; Aviram S; Schwartz O; Hai T; Aronheim A
Cardiovasc Res; 2017 Feb; 113(2):134-146. PubMed ID: 28082453
[TBL] [Abstract][Full Text] [Related]
14. Fatty Acid-Binding Protein 4 mediates apoptosis via endoplasmic reticulum stress in mesangial cells of diabetic nephropathy.
Yao F; Li Z; Ehara T; Yang L; Wang D; Feng L; Zhang Y; Wang K; Shi Y; Duan H; Zhang L
Mol Cell Endocrinol; 2015 Aug; 411():232-42. PubMed ID: 25958041
[TBL] [Abstract][Full Text] [Related]
15. Plasma glucose, triglycerides, VLDL, leptin and resistin levels as potential biomarkers for myocardial fat in mice.
Rodríguez-Calvo R; Samino S; Guaita-Esteruelas S; Martínez-Micaelo N; Heras M; Girona J; Yanes O; Correig X; Masana L
Clin Investig Arterioscler; 2020; 32(1):8-14. PubMed ID: 31221535
[TBL] [Abstract][Full Text] [Related]
16. Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes.
Cabré A; Lázaro I; Girona J; Manzanares JM; Marimón F; Plana N; Heras M; Masana L
J Lipid Res; 2008 Aug; 49(8):1746-51. PubMed ID: 18421072
[TBL] [Abstract][Full Text] [Related]
17. Cardiac lipid content is unresponsive to a physical activity training intervention in type 2 diabetic patients, despite improved ejection fraction.
Schrauwen-Hinderling VB; Meex RC; Hesselink MK; van de Weijer T; Leiner T; Schär M; Lamb HJ; Wildberger JE; Glatz JF; Schrauwen P; Kooi ME
Cardiovasc Diabetol; 2011 May; 10():47. PubMed ID: 21615922
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of MG53 induces diabetic cardiomyopathy through transcriptional activation of peroxisome proliferation-activated receptor α.
Liu F; Song R; Feng Y; Guo J; Chen Y; Zhang Y; Chen T; Wang Y; Huang Y; Li CY; Cao C; Zhang Y; Hu X; Xiao RP
Circulation; 2015 Mar; 131(9):795-804. PubMed ID: 25637627
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
[TBL] [Abstract][Full Text] [Related]
20. Role of 14-3-3η protein on cardiac fatty acid metabolism and macrophage polarization after high fat diet induced type 2 diabetes mellitus.
Sreedhar R; Arumugam S; Thandavarayan RA; Karuppagounder V; Koga Y; Nakamura T; Harima M; Watanabe K
Int J Biochem Cell Biol; 2017 Jul; 88():92-99. PubMed ID: 28483670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
